17
Allergies

Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation

Embed Size (px)

Citation preview

Page 1: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation

Allergies

Page 2: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation

Ocular Allergies

Page 3: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation

More than 20% population of the world is usually affected by different types of Ocular Allergies.

Allergic conjunctivitis is the most common and the most irritating one.

Page 4: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation

Conjunctivitis

Inflammation of the conjunctiva is called conjunctivitis

1. Bacterial Conjunctivitis2. Viral Conjunctivitis3. Allergic Conjunctivitis

Page 5: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation

Allergic conjunctivitis is inflammation of the conjunctiva due to allergic activities

Allergic Conjunctivitis

Page 6: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation

Allergic Conjunctivitis

Page 7: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation
Page 8: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation

Ensures excellent efficacy and greater tolerability2

…greater patient satisfaction by rapid symptomatic relief

Page 9: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation

•The best option for Allergic

Conjunctivitis treatment

•Better than Ephinastine in preventing

ocular itching & redness

•Ensures excellent efficacy and greater

tolerability

•Safe for children and adolescent

•Safe for long term use

Page 10: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation

Major indications:

1. Seasonal allergic conjunctivitis

2. Perennial allergic conjunctivitis

3. Allergic Keratitis

4. Allergic Kerato-conjunctivitis

Page 11: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation

Product Positioning

Physician Positions1. Ophthalmologist Allergic conjunctivitis, Allergic

Keratitis , Allergic Kerato-conjunctivitis

2. Pediatricians Pediatrici allergic conjunctivitis and keratitis

3. Potential GP & Medicine Sp. Allergic conjunctivitis, Allergic Keratitis , Allergic Kerato-conjunctivitis

Page 12: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation

Action Plan• Select Five doctors of your territory who are

prescribing Olopatadine DS

• Convey the special advantages of Olarif DS over

the competitor’s brands.

• Visit these doctors frequently until prescription

is achieved.

• Monitor prescription share of loyal doctors

• Make the best use of physician’s sample and

promotional tools to the target doctors for

increasing prescription support

Page 13: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation
Page 14: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation
Page 15: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation
Page 16: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation
Page 17: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation

THANK YOU